Aparajitha Verma, MD
Sleep Medicine · Houston, TXNPI 1750592408
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,854 of the $2,065 with a category attached, or 89.8%. It is spread thinly across 20 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations.
Across 46 payments — averaging $44.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$327
- Arbor Pharmaceuticals, Inc.$284
- Inspire Medical Systems, Inc.$275
- SK Life Science, Inc.$249
- Jazz Pharmaceuticals Inc.$190
- Amneal Pharmaceuticals LLC$129
- plus $611 from 14 others
What the payments were for
- Speaking & faculty fees$211%
- Food & beverage$1,85490%
- Education$1909%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 3 | $327 |
| Arbor Pharmaceuticals, Inc. | 15 | $284 |
| Inspire Medical Systems, Inc. | 7 | $275 |
| SK Life Science, Inc. | 4 | $249 |
| Jazz Pharmaceuticals Inc. | 2 | $190 |
| Amneal Pharmaceuticals LLC | 1 | $129 |
| Greenwich Biosciences, Inc. | 1 | $120 |
| ZOLL Respicardia, Inc. | 1 | $108 |
| Harmony Biosciences LLC | 1 | $96 |
| Novo Nordisk | 1 | $66 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $33 |
| Merz North America, Inc. | 1 | $24 |
| AbbVie | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Amgen | 1 | $21 |
| Acorda Therapeutics, Inc | 1 | $21 |
| Ambu Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $19 |
| Biogen | 1 | $19 |
| Grifols USA, LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$231
- CREXONT$129
- Inspire$128
- Epidiolex$120
- remede System$108
How this compares
$2,065 in reported general payments places this provider in the 55th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pramipexole DihydrochloridePramipexole Di-Hcl | 22 | $177 |
| Gabapentin | 17 | $162 |
| Clonazepam | 30 | $113 |
| Ropinirole Hcl | 15 | $101 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Houston
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- Leon RosenthalHouston$6K
- Kevin LinHouston$4K
- Calli BertschyHouston$3K
- Annise WilsonHouston$2K
- Amita Shimpi BhallaHouston$2K
- Cindy JonHouston$2K
- Meer AhmedHouston$2K
- Mauro Mendez BaylonHouston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.